Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients

Stanojković, Tatjana; Matić, Ivana Z.; Petrović, Nina; Stanković, Vesna; Kopčalić, Katarina; Besu, Irina; Crnogorac, Marija Äńordić; Mališić, Emina; Mirjacic-Martinovic, K.; Vuletić, Ana; Bukumirić, Zoran; Žižak, Željko; Veldwijk, Marlon R.; Herskind, Carsten; Nikitović, Marina

doi:10.1038/s41598-020-75812-0

Cited by 27 publications

(28 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…MicroRNA-34a also changes the expression profile of cytokines such as interleukin 6 (IL-6), and tumor necrosis factor alpha (TNFα), thus regulating the inflammatory response 27 . Besides that, it has been noticed that IL-6 and transforming growth factor beta ( TGF-β ) gene expression levels change in PBMC in prostate cancer patients receiving RT 38 . MicroRNA-10b was shown to decrease radiation-induced apoptosis in glioblastoma cells 25 .…”

Section: Discussionmentioning

confidence: 99%

Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide

Stepanović

Nikitović

Stanojković

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

A personalized approach to chemoradiation is important in reducing its potential side effects and identifying a group of patients prone to toxicity. MicroRNAs have been shown to have a predictive potential for radiotoxicity. The goal of the study was to test if levels of miRNA in peripheral blood mononuclear cells of glioblastoma patients are associated with toxicity and to identify the peak time point for toxicity. MicroRNA-10b/21/34a levels were measured in 43 patients with and without toxicity, at baseline, at the 15th, and at the 30th fraction by Real-Time quantitative Polymerase Chain Reaction. MicroRNA-10b/21 levels increased with toxicity grade (p = 0.014; p = 0.013); miR-21/34a levels were significantly different between patients with and without toxicity at the 15th fraction (p = 0.030; p = 0.045), while miR-34a levels significantly changed during treatment (p < 0.001). All three miRNAs showed a significantly high positive correlation with one another. MiR-34a might be considered as a predictive factor for toxicity due to its changes during treatment, and differences between the groups with and without toxicity; miR-10b might be used to predict toxicity; miR-10b/21 might be used for predicting the grade of toxicity in GB patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide

Stepanović

Nikitović

Stanojković

et al. 2022

Sci Rep

Self Cite

View full text Add to dashboard Cite

show abstract

“…IFN-γ and IL-6 increased significantly during IMRT, and the increased expression of IL-2 and IL-1 was related to acute gastrointestinal and genitourinary toxicity. In another study, circulating cytokine levels were assessed before RT, after 1, 3 and, 5 weeks, at RT completion, and 1 month after completion [ 24 ]. This study showed that IL-6 was significantly associated with the severity of acute genitourinary and gastrointestinal toxicity.…”

Section: Discussionmentioning

confidence: 99%

Cytokine Profiles of Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy with Regards to Radiation Pneumonitis Severity

Jeong

Kim

Jung

et al. 2021

JCM

View full text Add to dashboard Cite

The immunologic aspects of radiation pneumonitis (RP) are unclear. We analyzed variations in cytokine profiles between patients with grade (Gr) 0–1 and Gr ≥ 2 RP. Fifteen patients undergoing concurrent chemoradiotherapy for non-small cell lung cancer were included. Blood samples of 9 patients with Gr 0–1 and 6 with Gr ≥ 2 RP were obtained from the Biobank. Cytokine levels were evaluated using an enzyme linked immunosorbent assay at before radiotherapy (RT) initiation, 1, 3, and 6 weeks post-RT initiation, and 1 month post-RT completion. Concentrations of granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-10, IL-13, IL-17, interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β were analyzed; none were related to the occurrence of Gr ≥ 2 RP at pre-RT initiation. At 3 weeks, relative changes in the G-CSF, IL-6, and IFN-γ levels differed significantly between the groups (p = 0.026, 0.05 and 0.026, respectively). One month post-RT completion, relative changes of IL-17 showed significant differences (p = 0.045); however, relative changes in TNF-α, IL-10, IL-13, and TGF-β, did not differ significantly. Evaluation of changes in IL-6, G-CSF, and IFN-γ at 3 weeks after RT initiation can identify patients pre-disposed to severe RP. The mechanism of variation in cytokine levels in relation to RP severity warrants further investigation.

show abstract

“…The radiation-induced inflammatory response and specific changes in the levels of circulating cytokines have been associated with the occurrence of side effects in cancer patients undergoing radiotherapy, such as normal tissue radiotoxicity and fatigue symptoms [ 24 – 26 ]. In our previous studies, we have shown associations between individual, clinical factors, biological parameters, and the risk for development of acute radiotoxicity in patients with prostate cancer treated with radiotherapy [ 12 , 27 ]. The increased serum levels of IL-6 during the course of radiotherapy in patients with prostate cancer had been reported to be significantly associated with higher grade of acute GU toxicity across radiotherapy [ 27 ].…”

Section: Introductionmentioning

confidence: 99%

Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background The goal of research was to investigate the possible relations between serum concentrations of IL-6 and TGF-β1, individual and clinical characteristics, and adverse effects of radiotherapy in patients with prostate cancer: acute and late genitourinary and gastrointestinal toxicity, and fatigue. Methods Thirty-nine patients with localized or locally advanced prostate cancer who were treated with radiotherapy were enrolled in this study. The acute radiotoxicity grades and fatigue levels were assessed during the radiotherapy and 1 month after the radiotherapy. Estimation of the late radiotoxicity was performed every three months in the first year, every four months in the second year, and then every six months. Serum levels of IL-6 and TGF-β1 were determined before radiotherapy and after the 25th radiotherapy fraction by ELISA. Results The significant positive association between diabetes mellitus and changes in acute genitourinary toxicity grades during the radiotherapy was observed in prostate cancer patients. In addition, patients who were smokers had significantly higher maximum fatigue levels in comparison with patients who were non-smokers. The circulating IL-6 levels were significantly higher after the 25th radiotherapy fraction in comparison with levels determined before radiotherapy. The significant positive correlations between pretreatment TGF-β1 levels and maximum genitourinary toxicity grades and between TGF-β1 levels after the 25th fraction and genitourinary toxicity grades after the 25th fraction, were found. The pretreatment IL-6 concentrations and TGF-β1 concentrations after the 25th fraction were positively correlated with maximum genitourinary toxicity grades. The IL-6 levels after the 25th fraction were positively associated with genitourinary toxicity grades after this fraction. The pretreatment IL-6 concentrations were significantly positively correlated with maximum fatigue scores. The significant positive correlation between IL-6 concentrations and fatigue scores after the 25th fraction was determined. The positive correlations between IL-6 and TGF-β1 concentrations measured after the 25th fraction and maximum fatigue scores were observed. Conclusions Our results suggest that serum levels of IL-6 and TGF-β1 might influence the severity of acute genitourinary radiotoxicity and fatigue in patients with prostate cancer. Combining clinical parameters and circulating cytokine levels might be useful for the prediction of adverse reactions to radiotherapy.

show abstract

Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients

Cited by 27 publications

References 33 publications

Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide

Association between microRNAs 10b/21/34a and acute toxicity in glioblastoma patients treated with radiotherapy and temozolomide

Cytokine Profiles of Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy with Regards to Radiation Pneumonitis Severity

Circulating levels of IL-6 and TGF-β1 in patients with prostate cancer undergoing radiotherapy: associations with acute radiotoxicity and fatigue symptoms

Contact Info

Product

Resources

About